DIAGNOSTIC TEST 871
Neurochondrin Antibodies (IgG)
Diagnostic test for antibodies against Neurochondrin. For suspicion of autoimmune cerebellar ataxia.
Indication
Suspicion of autoimmune cerebellar ataxia
Sample material
Serum
- Minim. volume: 0,5 mL
CSF
- Minim. volume: 0,5 mL
Transport
- Within Sweden: room temperature
- International: cold
Method
Cell-based assay (CBA), indirect immunofluorescence (IIF)
Reference interval
Serum: <1:100 negative
CSF: negative
Result
Results are reported as negative or positive. A positive result is followed by a titer (serum).
Interpretation
Antibodies against neurochondrin have been reported in cases with autoimmune cerebellar degeneration with rapidly progressive cerebellar ataxia. They are usually not associated with malignancy.
References
- Ahmad R et al. Front Immunol. 2024. Case report: Refractory focal motor seizure associated with cerebrospinal fluid neurochondrin antibody. PMID: 39376559
- Schwarzwald A et al. Eur J Neurol. 2023. Anti-neurochondrin antibody as a biomarker in primary autoimmune cerebellar ataxia-a case report and review of the literature. PMID: 36437687
- Schwarzwald A et al. Eur J Neurol. 2023. Anti-neurochondrin antibody as a biomarker in primary autoimmune cerebellar ataxia-a case report and review of the literature. PMID: 36437687
Need pricing information?
How to order
This test is available worldwide for hospitals, clinics, and physicians.
-
Print and complete the request form
Download the request form. Clearly state the name and phone number of the referring hospital, clinic, or physician. -
Prepare your samples
Serum: At least 0.5 mL serum (plain serum tubes without additives).
CSF: At least 0.5 mL CSF (polypropylene tubes).
-
Send samples and request form
Within Sweden
Samples can be sent at room temperature to:
Envelopes and smaller boxes:
Wieslab AB, Box 50117, 20211 Malmö, Sweden
Larger boxes and frozen samples:
Wieslab AB, Lundavägen 151, 21224 Malmö, Sweden
International
Send samples cold to:
Wieslab AB, Lundavägen 151, 21224 Malmö, Sweden
Last updated: 2025-12-05